Harrow Health, Inc. (HROW) — Financial statements
Income statement, balance sheet, and cash flow for Harrow Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 272↑36.4% | 200↑53.3% | 130↑47.0% | 89↑22.2% | 72 | |
| Cost of Revenue | 68↑38.0% | 49↑24.2% | 40↑56.2% | 25↑39.4% | 18 | |
| Gross Profit | 204↑35.9% | 150↑66.1% | 91↑43.3% | 63↑16.5% | 54 | |
| Operating Expenses | ||||||
| R&D Expenses | 13↑5.0% | 12↑83.9% | 7↑118.1% | 3↓72.5% | 11 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 153 | 0.00 | 0.00 | 0.00↓100.0% | 40 | |
| Other Expenses | 0.00↓100.0% | 129↑54.9% | 83↑43.3% | 58↑3230.1% | 2 | |
| Operating Expenses | 166↑17.1% | 142↑57.1% | 90↑47.0% | 61↑16.4% | 53 | |
| Total Costs & Expenses | 234↑22.5% | 191↑47.0% | 130↑49.7% | 87↑22.3% | 71 | |
| Operating Results | ||||||
| Operating Income | 39↑337.6% | 9↑1946.9% | 0.43↓77.5% | 2↑18.9% | 2 | |
| Depreciation & Amortization | 19↑44.9% | 13↑17.2% | 11↑293.4% | 3↑62.6% | 2 | |
| EBITDA | 58↑159.9% | 22↑85.2% | 12↑151.5% | 5↓6.9% | 5 | |
| EBIT | 39↑325.4% | 9↑1019.0% | 0.81↓57.7% | 2↓42.9% | 3 | |
| Interest & Other Income | ||||||
| Net Interest Income | -24↓6.1% | -23↓6.9% | -21↓194.4% | -7↓33.3% | -5 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 24↑6.1% | 23↑6.9% | 21↑194.4% | 7↑33.3% | 5 | |
| Non-Operating Income | 0.00↑100.0% | -0.25↑33.4% | -0.38 | 0.00↑100.0% | -2 | |
| Other Income / Expenses | -40↓54.3% | -26↓8.3% | -24↓51.5% | -16↑18.3% | -19 | |
| Income Before Tax | -2↑90.0% | -17↑27.0% | -24↓69.2% | -14↑21.6% | -18 | |
| Income Tax Expense | 3↑2021.1% | 0.16↓77.0% | 0.70↑834.7% | 0.08↓43.6% | 0.13 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -5↑70.6% | -17↑28.4% | -24↓73.3% | -14↑21.8% | -18 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -5↑70.6% | -17↑28.4% | -24↓73.3% | -14↑21.8% | -18 | |
| Bottom-Line Net Income | -5↑70.6% | -17↑28.4% | -24↓73.3% | -14↑23.8% | -18 | |
| EPS (Basic) | -0.14↑71.4% | -0.49↑34.7% | -0.75↓47.1% | -0.51↑26.1% | -0.69 | |
| EPS (Diluted) | -0.14↑71.4% | -0.49↑34.7% | -0.75↓47.1% | -0.51↑26.1% | -0.69 | |
| Weighted Average Shares | 37↑3.1% | 36↑9.3% | 33↑18.8% | 27↑2.6% | 27 | |
| Weighted Average Diluted Shares | 37↑3.1% | 36↑9.3% | 33↑18.8% | 27↑2.6% | 27 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.